IMMUNITY PHARMA
Immunity Pharma specializes in developing therapies for neurodegenerative diseases. Its initial is focus on Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
IMMUNITY PHARMA
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2007-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.immunitypharma.com
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Universal Analytics Font Awesome Apache ReCAPTCHA DigiCert SSL
Similar Organizations
ARTham Therapeutics
ARTham Therapeutics is a biopharmaceutical company that delivers drugs to help patients.
B-SMART
B-SMART is an RNA-based therapy perspective for neurodegenerative diseases.
BioCorteX
BioCorteX is a pharmaceutical company specializing in enhanced therapeutics to cure neurodegenerative diseases using microorganisms.
Fujirebio
Fujirebio provides clinical test drugs for infectious diseases, tumors, and lifestyle-related diseases.
Galenea
Galenea is engaged in developing therapeutics for central nervous system diseases.
Immunitor
Immunitor develops orally-delivered immunotherapies for a number of serious diseases affecting the world.
MAGiQ Therapeutics
MAGiQ Therapeutics focuses on the development and licensing of regenerative medicine products generated from iPS cells.
NAL Pharma
NAL Pharma is a specialty drug developer that develops novel dosage forms.
Neuromagen Pharma
Neuromagen Pharma develops drugs for neurodegenerative diseases including ALS.
ParaPRO
ParaPRO specializes in developing therapies for parasite infestations that afflict millions of people every year.
SALIAI
SALIAI is a developer of the stem cell and regenerative medicine solution provider.
Takeda Cambridge
Takeda Cambridge specializes in developing oral diabetes medications.
Tavec pharma
Tavec Pharmaceuticals is developing injectable therapies to treat cancers.
YAbA
YAbA has specializes in developing diagnostic tests for veternizary diseases.
Current Employees Featured
Founder
Official Site Inspections
http://www.immunitypharma.com Semrush global rank: 6.14 M Semrush visits lastest month: 1.32 K
- Host name: dedi3509.your-server.de
- IP address: 78.46.191.201
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Immunity Pharma"
Board of Directors - Immunity Pharma
Oren M. Becker, Ph.D. Dr. Becker is a co-Founder and member of the Board of Directors of Immunity Pharma. He brings more than 20 years of biopharmaceutical industry and leadership …See details»
About IPL - Immunity Pharma
About IPL. Immunity Pharma Ltd. (IPL) is a clinical stage biopharma company that develops therapies for neurodegenerative diseases with an initial focus on amyotrophic lateral sclerosis (ALS).See details»
Immunity Pharma Company Profile | Management and Employees …
Www.immunitypharma.com Immunity Pharma Profile and History Immunity Pharma Ltd. (IPL) is a privately-held clinical-stage neurology-focused biopharmaceutical company that develops …See details»
Immunity Pharma - Crunchbase Company Profile & Funding
Www.immunitypharma.com ; 439,118; Highlights. Employee Profiles 1. Similar Companies 29. Recent News & Activity. There is no recent news or activity for this profile. ... Sub-Organization …See details»
Immunity Pharma Ltd. - Drug pipelines, Patents, Clinical trials
Www.immunitypharma.com. Private Company | 2007 | Israel | www.immunitypharma.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & …See details»
Immunity Pharma Company Profile 2024: Valuation, Funding
Mar 8, 2022 Information on valuation, funding, cap tables, investors, and executives for Immunity Pharma. Use the PitchBook Platform to explore the full profile.See details»
Immunity Pharma Ltd. | Mevaseret Zion, Israel Startup
Website immunitypharma.com; Company Summary We develop innovative drugs that stimulate pro-survival cell-signaling processes for the treatment of neuro-degenerative diseases. Our …See details»
IMMUNITY - PHARMA LTD Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for IMMUNITY - PHARMA LTD of MEVASSERET ZION, Jerusalem Area. Get the latest business insights from …See details»
Immunity Pharma - Overview, News & Similar companies - ZoomInfo
Jan 16, 2024 Immunity Pharma Announces Positive Top Line Results from Phase 2a Trial with IPL344 in ALS Patients Treatment with IPL344 was well tolerated Changes in the slope of …See details»
Management Team - Immunity Pharma
Immunity Pharma is a drug development company that uses novel immune-based approaches to develop therapies for neuro-degenerative and inflammatory diseases.See details»
Immunity Pharma Announces Promising Interim Results
JERUSALEM, Sept. 14, 2020 /PRNewswire/ -- Immunity Pharma, a clinical-stage neurology-focused biopharmaceutical company, announced today interim results from its Phase 1/2a …See details»
Immunity Pharma Announces Positive Top Line Results from Phase …
Jan 17, 2024 /PRNewswire/ -- Immunity Pharma, a clinical-stage neurology-focused biopharmaceutical company, today announced positive top line results from the Phase 2a...See details»
Immunity Pharma gears up for pivotal trial with ALS drug
Jan 18, 2024 Immunity Pharma CEO, Eran Ovadia, said that the Phase IIa data gives the company confidence to progress the candidate to Phase III. The trial demonstrated that once …See details»
Contact - Immunity Pharma
Immunity Pharma is a drug development company that uses novel immune-based approaches to develop therapies for neuro-degenerative and inflammatory diseases.See details»
Immunity Pharma Announces Promising Interim Results of its …
JERUSALEM, Sept. 14, 2020 /PRNewswire/ -- Immunity Pharma, a clinical-stage neurology-focused biopharmaceutical company, announced today interim results from its Phase 1/2a …See details»
International Immunopharmacology | Journal - ScienceDirect
International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, …See details»
News - Immunity Pharma
Jan 16, 2024 For more information, please visit www.immunitypharma.com. Neurofilament (NfL) Reduction Following IPL344 Treatment of ALS Patients . Jerusalem, Israel, December 10, …See details»
CIPO unveils our new name and brand, ImmUnity Canada
Oct 2, 2022 As we celebrate our 25th anniversary, we are thrilled to announce that the Canadian Immunodeficiencies Patient Organization (CIPO) is rebranding to ImmUnity Canada. What to …See details»
Press Releases - Immunity Pharma
Jerusalem, Israel, December 10, 2023 Indication of neurodegeneration slow down following IPL344 treatment; Immunity Pharma, a clinical-stage neurology-focusedSee details»